Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus

M. V. Betkerur, T. F. Yeh, K. Miller, R. J. Glasser, R. S. Pildes

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

In the course of a double-blind trial of intravenous indomethacin therapy in premature infants with patent ductus arteriosus, renal function and urinary kallikrein were studied in 21 infants following one dose of either saline placebo or indomethacin. Ten infants were assigned to the control group and 11 were in the indomethacin group. Significantly lower urine output, fraction excretion of sodium, fraction excretion of chloride, and urinary kallikrein were noted by 45%, 59%, 63%, and 51%, respectively, in the indomethacin group as compared to the control group. There was a concomitant decrease in serum sodium concentration (P<.05) at 24 hours following indomethacin therapy. No significant difference in glomerular filtration rate was seen between the control group and the indomethacin-treated infants.

Original languageEnglish
Pages (from-to)99-102
Number of pages4
JournalPediatrics
Volume68
Issue number1
Publication statusPublished - Nov 9 1981
Externally publishedYes

Fingerprint

Tissue Kallikreins
Patent Ductus Arteriosus
Premature Infants
Indomethacin
Kidney
Control Groups
Sodium
Glomerular Filtration Rate
Chlorides
Placebos
Urine
Therapeutics
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. / Betkerur, M. V.; Yeh, T. F.; Miller, K.; Glasser, R. J.; Pildes, R. S.

In: Pediatrics, Vol. 68, No. 1, 09.11.1981, p. 99-102.

Research output: Contribution to journalArticle

Betkerur, M. V. ; Yeh, T. F. ; Miller, K. ; Glasser, R. J. ; Pildes, R. S. / Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. In: Pediatrics. 1981 ; Vol. 68, No. 1. pp. 99-102.
@article{093c0cb6507f4fd9a6f9c8c8f3d6494c,
title = "Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus",
abstract = "In the course of a double-blind trial of intravenous indomethacin therapy in premature infants with patent ductus arteriosus, renal function and urinary kallikrein were studied in 21 infants following one dose of either saline placebo or indomethacin. Ten infants were assigned to the control group and 11 were in the indomethacin group. Significantly lower urine output, fraction excretion of sodium, fraction excretion of chloride, and urinary kallikrein were noted by 45{\%}, 59{\%}, 63{\%}, and 51{\%}, respectively, in the indomethacin group as compared to the control group. There was a concomitant decrease in serum sodium concentration (P<.05) at 24 hours following indomethacin therapy. No significant difference in glomerular filtration rate was seen between the control group and the indomethacin-treated infants.",
author = "Betkerur, {M. V.} and Yeh, {T. F.} and K. Miller and Glasser, {R. J.} and Pildes, {R. S.}",
year = "1981",
month = "11",
day = "9",
language = "English",
volume = "68",
pages = "99--102",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus

AU - Betkerur, M. V.

AU - Yeh, T. F.

AU - Miller, K.

AU - Glasser, R. J.

AU - Pildes, R. S.

PY - 1981/11/9

Y1 - 1981/11/9

N2 - In the course of a double-blind trial of intravenous indomethacin therapy in premature infants with patent ductus arteriosus, renal function and urinary kallikrein were studied in 21 infants following one dose of either saline placebo or indomethacin. Ten infants were assigned to the control group and 11 were in the indomethacin group. Significantly lower urine output, fraction excretion of sodium, fraction excretion of chloride, and urinary kallikrein were noted by 45%, 59%, 63%, and 51%, respectively, in the indomethacin group as compared to the control group. There was a concomitant decrease in serum sodium concentration (P<.05) at 24 hours following indomethacin therapy. No significant difference in glomerular filtration rate was seen between the control group and the indomethacin-treated infants.

AB - In the course of a double-blind trial of intravenous indomethacin therapy in premature infants with patent ductus arteriosus, renal function and urinary kallikrein were studied in 21 infants following one dose of either saline placebo or indomethacin. Ten infants were assigned to the control group and 11 were in the indomethacin group. Significantly lower urine output, fraction excretion of sodium, fraction excretion of chloride, and urinary kallikrein were noted by 45%, 59%, 63%, and 51%, respectively, in the indomethacin group as compared to the control group. There was a concomitant decrease in serum sodium concentration (P<.05) at 24 hours following indomethacin therapy. No significant difference in glomerular filtration rate was seen between the control group and the indomethacin-treated infants.

UR - http://www.scopus.com/inward/record.url?scp=0019442238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019442238&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 99

EP - 102

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -